Document Detail


Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinonin.
MedLine Citation:
PMID:  18313309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A series of hybrid compounds of bestatin (1) and actinonin (3), which promote degradation of cellular inhibitor of apoptosis protein 1 (cIAP1), were designed and synthesized. Structure-activity relationship studies indicated that absolute configuration, hydrophobicity at the alpha-position of the internal amide carbonyl group, and the presence of a small substituent at the alpha-position of the ester group are important factors for the expression of potent cIAP1 degradation-promoting activity. HAB-5A (30b) showed the most potent activity (IC(50)=0.53 microM) among the compounds prepared.
Authors:
Shinichi Sato; Masashi Tetsuhashi; Keiko Sekine; Hiroyuki Miyachi; Mikihiko Naito; Yuichi Hashimoto; Hiroshi Aoyama
Related Documents :
12562089 - Selective action of acetogenin mitochondrial complex i inhibitors.
20024979 - 5-benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial mur ligases.
9667959 - Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid ...
19326339 - Bioactivation of selenocysteine derivatives by beta-lyases present in common gastrointe...
17004709 - Using fragment cocktail crystallography to assist inhibitor design of trypanosoma bruce...
24888439 - Dihydroisoxazole inhibitors of anopheles gambiae seminal transglutaminase agtg3.
25404739 - The first crystal structure of a dttp bound deoxycytidylate deaminase validates and det...
19026549 - Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) as inhibitors of gastric acid secr...
24883179 - The evolving role of flt3 inhibitors in acute myeloid leukemia: quizartinib and beyond.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-02-13
Journal Detail:
Title:  Bioorganic & medicinal chemistry     Volume:  16     ISSN:  1464-3391     ISO Abbreviation:  Bioorg. Med. Chem.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-04-24     Completed Date:  2008-05-21     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9413298     Medline TA:  Bioorg Med Chem     Country:  England    
Other Details:
Languages:  eng     Pagination:  4685-98     Citation Subset:  IM    
Affiliation:
Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Tokyo 113-0032, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects
Cell Line, Tumor
Humans
Hydroxamic Acids / chemical synthesis,  chemistry,  pharmacology
Inhibitor of Apoptosis Proteins / genetics*,  metabolism*
Inhibitory Concentration 50
Leucine / analogs & derivatives*,  chemical synthesis,  chemistry,  pharmacology
Molecular Structure
Promoter Regions, Genetic / genetics*
Structure-Activity Relationship
Chemical
Reg. No./Substance:
0/Hydroxamic Acids; 0/Inhibitor of Apoptosis Proteins; 13434-13-4/actinonin; 58970-76-6/bestatin; 61-90-5/Leucine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other en...
Next Document:  Proteasome inhibition by peptide-semicarbazones.